PlainPatent
USPTO 2015–2025 USPTO PatentsView US Corporation

Calico Life Sciences LLC

USPTO PatentsView assignee record - 5 granted patents across 8 technology areas, recorded in grant years 2020–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (Heterocyclic Compounds).

RSS updates for this company
Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Calico ranks #45,425 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 8 technology areas.

#45,425
of 49,997 US assignees by volume
36th percentile
by Innovation Score (30.8/100)
17.0
avg claims per patent

USPTO PatentsView assignee plate

Corpus R45425 · US Corporation #45,425 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-MICRO 5 grants
  • BOTTOM-DECILE #45,425/49,997
  • PHOTO-FINISH Cairn5
  • CPC-NARROW C07D · 8 areas
  • INNOV-THIN 30.8/100
  • CLAIMS-RICH 17.0 claims/avg
  • TYPE-USCORP US Corporation
  • SPAN-YRS 2020–2024 · 5y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Cairn5 LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Calico’s 30.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Calico

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Calico's Innovation Score is 30.8/100 (36th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Calico?

Each dot is one of Calico’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Calico’s own 17.0 claims/patent is at or below the 19.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Calico vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 4.95.05.055.05.05.1 510152025 Granted patents (volume) Avg claims / patent Cairn5 LLC - 5, 22.2Cairn5Calcivis Limited - 5, 20CalcivisCaliber Therapeutics, LLC - 5, 8.2Caliber Therapeut…Calibo LLC - 5, 20.6CaliboCambi Technology AS - 5, 14Cambi Technology…Cambridge Engineering, Inc. - 5, 20.4Cambridge Enginee…Cambridge Epigenetix Limited - 5, 19Cambridge Epigene…Cambridge Medical Technologies LLC - 5, 15.2Cambridge MedicalCalico Life Sciences LLC - 5, 17Calico Life Scien…
Calico vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Calico's grants concentrate

Calico Life Sciences LLC is a focused PatentsView assignee: 8 CPC subclasses with 40% of grants classified under C07D (Heterocyclic Compounds). Peak complete grant year is 2021 (2 grants) versus a trough of 1 in 2020. By volume, Calico sits between Cairn5 LLC and Cambridge Medical Technologies LLC.

Calico's three-year grant acceleration

Calico Life Sciences LLC shows 2 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Calico's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Calico holds 5 patents at rank #45,719, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Calico

By rank, the assignees closest to #45,719 in granted patent volume.

Leaders in C07D (Heterocyclic Compounds)

Other assignees with the most granted patents in Calico's primary technology class.

Calico's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

31 36th percentile higher than 36% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.5 2020202120232024 1
USPTO utility patent grants by year · 2020–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table
Calico Life Sciences LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2020 1 20.0%
2021 2 40.0%
2023 1 20.0%
2024 1 20.0%

Which technologies does Calico Life Sciences LLC patent most?

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Calico Life Sciences LLC's patent record in context - here's where to go next.

  • Calico Life Sciences LLC's lead technology class is C07D (Heterocyclic Compounds), 40% of its portfolio - see every assignee active in that class. Explore C07D
  • Ranked #45,425 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Calico Life Sciences LLC against Cairn5 LLC, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 30.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.